olaparib,bevacizumab
roche,astrazeneca,merck
['avastin', 'lynparza', 'merck', 'astrazeneca']
#esmo22: at five-year mark, lynparza kept more patients alive than avastin but missed overall os significance - more like this | #oncology #research #pharma #lynparza #clinicaltrialsdata #biotech #lifesciences 
We help biotech scientists improve the lives of patients by accelerating & scaling drug discovery, cancer research and diagnostic development.